Bristol-Myers Squibb R&D increased by 2.4% to $2.65B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.4%, from $2.26B to $2.65B. Over 4 years (FY 2021 to FY 2025), R&D shows relatively stable performance with a -0.6% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.48B | $2.98B | $2.52B | $2.26B | $2.32B | $2.42B | $2.51B | $2.32B | $2.26B | $2.24B | $2.48B | $2.70B | $2.90B | $2.37B | $3.19B | $2.26B | $2.58B | $2.53B | $2.59B | $2.65B |
| QoQ Change | — | +20.3% | -15.5% | -10.2% | +2.7% | +4.2% | +3.8% | -7.5% | -2.7% | -0.7% | +10.5% | +8.8% | +7.6% | -18.1% | +34.4% | -29.3% | +14.3% | -2.0% | +2.3% | +2.4% |
| YoY Change | — | — | — | — | -6.3% | -18.9% | -0.3% | +2.7% | -2.7% | -7.3% | -1.3% | +16.1% | +28.4% | +5.9% | +28.8% | -16.3% | -11.0% | +6.5% | -19.0% | +17.4% |
Range$2.24B – $3.19B
CAGR+1.4%
Avg YoY Growth+1.4%
Median YoY Growth-0.8%
Current Streak2 quarters growth
R&D at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's r&d?
- Bristol-Myers Squibb (BMY) reported r&d of $2.65B in Q1 2026.
- How has Bristol-Myers Squibb's r&d changed year-over-year?
- Bristol-Myers Squibb's r&d increased by 17.4% year-over-year, from $2.26B to $2.65B.
- What is the long-term trend for Bristol-Myers Squibb's r&d?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's r&d has grown at a -0.6% compound annual growth rate (CAGR), from $10.20B to $9.95B.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.